BioHarvest Sciences Inc. - Common Stock (NASDAQ:BHST) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 41.18 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $9.100 million which missed the analyst consensus estimate of $9.279 million by 1.93 percent. This is a 24.66 percent increase over sales of $7.300 million the same period last year.